Compare ADCT & HOFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADCT | HOFT |
|---|---|---|
| Founded | 2011 | 1924 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.1M | 160.4M |
| IPO Year | 2019 | 1999 |
| Metric | ADCT | HOFT |
|---|---|---|
| Price | $1.13 | $14.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | ★ 796.4K | 52.8K |
| Earning Date | 05-04-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 3.79% |
| EPS Growth | ★ 30.86 | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $81,357,000.00 | ★ $278,139,000.00 |
| Revenue This Year | N/A | $17.37 |
| Revenue Next Year | $66.49 | $9.00 |
| P/E Ratio | ★ N/A | $154.30 |
| Revenue Growth | ★ 14.85 | N/A |
| 52 Week Low | $0.78 | $8.62 |
| 52 Week High | $4.98 | $18.09 |
| Indicator | ADCT | HOFT |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 52.72 |
| Support Level | $1.03 | $13.54 |
| Resistance Level | $1.17 | $15.97 |
| Average True Range (ATR) | 0.07 | 0.74 |
| MACD | 0.02 | 0.16 |
| Stochastic Oscillator | 41.18 | 73.43 |
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
Hooker Furnishings Corp is a designer, marketer, and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality, and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segments: Hooker Branded segment, Domestic Upholstery segment, and All Other. It generates the majority of its revenue from the Hooker Branded segment.